RAPT Therapeutics, Inc. (RAPT) Financials

RAPT Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 173.3 million 26.3 million
2023-09-30 199.7 million 26.9 million
2023-06-30 220.8 million 21.1 million
2023-03-31 248.3 million 27.9 million

RAPT Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 -27.8 million 4.4 million
2023-09-30 -22.0 million 4.3 million
2023-06-30 -29.0 million 4.2 million
2023-03-31 -19.4 million 4.1 million

RAPT Net Income

No data available :(

RAPT Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 158.9 million - 6.9 million
2023-09-30 184.8 million - 7.5 million
2023-06-30 205.0 million - 8.0 million
2023-03-31 231.6 million - 8.5 million

RAPT Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 38.4 million
2023-09-30 38.4 million
2023-06-30 38.3 million
2023-03-31 38.3 million

RAPT Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 67000 26.8 million 6.5 million -323000
2023-09-30 66000 27.0 million 6.9 million -
2023-06-30 233000 21.6 million 6.7 million -
2023-03-31 759000 25.6 million 6.0 million -

RAPT Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 - 323000
2023-09-30 - 908000
2023-06-30 - 853000
2023-03-31 - 883000

RAPT

Price: $8.18

52 week price:
6.86
27.35

Earnings Per Share: -3.05 USD

P/E Ratio: -9.06

Exchange: NGM

Sector: Healthcare

Industry: Biotechnology

Volume: 309600

Market Capitalization: 278.7 million

Links: